1 year return (CAGR)
41.24%
Vanda Pharmaceuticals Inc Exchange (NASDAQ, USD)
VNDA
5.04
-0.23 (-3.69%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
0.77%
5 year return (CAGR)
-19.25%
10 year return (CAGR)
-4.35%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
368.63M
Price/Sales
1.71
Ent value
445.54M
Price/Book
1.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 6.34 |
| Daily high | 6.35 |
| Daily low | 6.12 |
| Daily Volume | 927K |
| All-time high | 31.67 |
| 1y analyst estimate | 12.19 |
| Beta | 0.64 |
| EPS (TTM) | -4.56 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| VNDA | S&P500 | |
| Current price drop from All-time high | -84.09% | -1.29% |
| Highest price drop | -98.42% | -56.47% |
| Date of highest drop | 31 Dec 2008 | 9 Mar 2009 |
| Avg drop from high | -65.07% | -10.68% |
| Avg time to new high | 220 days | 12 days |
| Max time to new high | 4869 days | 1805 days |
News
